
Objective To estimate the effective refractive error coverage (eREC) for distance vision and identify factors associated with distance visual impairment (VI) among adults aged 30 years and above in rural Odisha, India.Methods and analysis A community-based cross-sectional study was conducted in rural Khordha district, Odisha, between May 2024 and December 2025. A multistage cluster sampling technique was employed to recruit 1800 eligible adults from 30 clusters across six Gram Panchayats. Distance visual acuity was assessed using a standardised tumbling ‘E’ chart. eREC and refractive error coverage (REC) for distance vision were estimated using WHO definitions. Sociodemographic determinants of VI were analysed using unadjusted and multivariable logistic regression models.Results Of the 1800 individuals approached, 1747 participated (response rate: 97.06%). The age–sex standardised prevalence of VI and blindness was 20.55% (95% CI 18.85 to 22.25). Mild VI was the most common category (14.20%), followed by moderate VI (7.67%). Among participants aged ≥30 years, REC was 67.33%, and eREC was 46.53%. eREC declined with increasing age. Increasing age was strongly associated with VI, whereas higher educational status demonstrated a protective effect.Conclusion The study demonstrates a high burden of VI and suboptimal eREC in rural Odisha. Despite moderate service coverage, significant quality gaps persist. Study limitations include restricting sampling to a single rural block, which may limit regional generalisability, and reliance on field-based visual acuity assessment rather than full clinical refraction. Nevertheless, strengthening the quality, accessibility and follow-up of primary refractive services is essential to eliminate quality gaps and achieve universal eye health coverage.
Introduction Central serous chorioretinopathy (CSCR) is characterised by serous retinal detachment due to subretinal fluid (SRF) accumulation, often involving the fovea, with chronic disease leading to retinal pigment epithelium dysfunction, photoreceptor damage and potential irreversible visual loss. Emerging evidence implicates the angiopoietin/Tie-2 pathway in choroidal vascular instability and disease pathogenesis. Faricimab is a bispecific antibody targeting both vascular endothelial growth factor-A and angiopoietin-2, providing a mechanistic rationale for its use in CSCR. This study aims to evaluate the efficacy and safety of intravitreal faricimab compared with sham treatment in chronic non-neovascular CSCR.Methods and analysis This is a prospective, randomised, double-masked, sham-controlled crossover, single-centre, investigator-initiated clinical trial conducted at the Singapore National Eye Centre. Fifty adults with chronic CSCR and foveal SRF, without secondary macular neovascularisation, will be enrolled and randomised 1:1 to receive intravitreal faricimab 6 mg or sham injections at baseline, Month 1 and Month 2, followed by pro re nata (PRN) faricimab treatment from Month 3 to Month 5 in both study arms.The primary endpoint is the proportion of eyes achieving complete SRF resolution at Month 3. Secondary outcomes include anatomical and functional measures, treatment burden and exploratory imaging biomarkers at Month 3 and Month 6.Ethics and dissemination This study will be conducted in accordance with the Declaration of Helsinki, International Council for Harmonisation Good Clinical Practice guidelines and applicable local regulatory requirements. Ethics approval from the SingHealth Centralised Institutional Review Board is pending. Recruitment will commence only after ethics approval has been obtained.Trial registration number NCT07681167
Objective To examine the correlation between the EuroQol 5-Dimension 5-Level (EQ-5D-5L) and Impact of Vision Impairment (IVI) questionnaire scores and evaluate their measurement performance among patients with cataract.Methods and analysis This cross-sectional study was conducted among patients with cataract attending a primary healthcare facility. Data were collected on visual acuity (VA) and quality of life (QoL) through interviews using the EQ-5D-5L and the IVI questionnaires. Spearman’s rho (ρ) was used to assess correlations. Rasch analysis evaluated precision and targeting of each instrument. Analyses were performed for both the total scores and three domains corresponding to IVI subscales: physical mobility/independence (PI), functional activities/tasks (FT) and distress/emotional well-being (DE).Results Ninety-eight patients were included. Mean presenting VA was 0.85±0.68 logMAR (better eye) and 1.92±0.58 logMAR (worse eye). Low to moderate positive correlations were found between the EQ-5D-5L and IVI total scores (ρ=0.572, p<0.001), and for all domains: PI (ρ=0.216, p=0.032), FT (ρ=0.573, p<0.001) and DE (ρ=0.570, p<0.001). A significant correlation with VA in the better eye was observed only for the FT domain of EQ-5D-5L. The IVI, including all subscales, demonstrated high precision (person separation reliability, person separation reliability >0.70), whereas the EQ-5D-5L showed poor precision (0.08). The FT domain of IVI (reading and accessing information subscale) exhibited the best targeting among patients with cataract.Conclusions Both instruments captured QoL aspects affected by cataract, showing a moderate positive correlation. The IVI demonstrated superior precision and targeting, particularly in reading-related items. Using both tools offers a comprehensive assessment of vision-specific and general QoL in patients with cataract.
Background Myopia has emerged as a major global public health challenge, with an urgent need for effective treatment strategies. Repeated low-level red light (RLRL) therapy has recently gained attention as a promising approach, with an increasing number of meta-analyses revealing its efficacy in myopia management. Therefore, we conducted the umbrella review to illustrate the overall evidence landscape, assess the reliability of previous studies, and identify potential evidence gaps of RLRL therapy for myopia control in children.Methods We searched PubMed, Embase, Scopus, Cochrane Library, CNKI, Wanfang, Epistemonikos and Web of Science up to 13 February 2026. Systematic reviews and meta-analyses primarily comparing RLRL with single-vision spectacles in myopic children were eligible. Primary outcomes were changes in axial length and spherical equivalent refraction. Subgroup, meta-regression and sensitivity analyses were conducted.Results 22 systematic reviews involving 73 993 participants were included, with 14 contributing to the primary meta-analysis. RLRL significantly reduced axial elongation (mean difference (MD): −0.24 mm, 95% CI −0.27 to −0.20) and spherical equivalent refraction progression (MD: 0.49 D, 95% CI 0.41 to 0.57). Subgroup analyses revealed increased treatment effect with longer follow-up (p<0.001). Sensitivity analyses confirmed the robustness of the findings.Conclusions RLRL therapy is an effective intervention for slowing myopia progression in children, with longer follow-up duration associated with greater efficacy. However, its safety profile still requires further validation.
Objectives This scoping review aims to investigate and thematically analyse the current evidence for storage and handling of ocular fluid samples for the purpose of cytokine analysis.Methods A comprehensive literature search was conducted in Ovid MEDLINE, Ovid EMBASE, Cochrane Central Register of Controlled Trials and Web of Science from inception until February 2025. Studies involving human adult or paediatric ocular fluid with >five samples were included if they compared collection, handling or storage methods.Results A total of 30 studies met the inclusion criteria. Preservation of cell integrity depends on ocular fluid type and biomarker of interest. For vitreous fluid collection, no statistical difference was found in protein concentration and profile between Millipore filters and micropipettes; both techniques revealed higher concentrations using Schirmer strips and microsponges. If lipids are of interest, collecting flush or reflex tears was inappropriate as concentration levels are significantly higher in basal samples. If the target is intracellular proteins, Schirmer strips will yield higher concentrations; however, capillary tubes yield higher concentrations for extracellular proteins. For sample handling, an optimal solution demonstrated that ammonium bicarbonate buffer yielded better protein results using Schirmer strips. For aqueous fluid samples, freezing and delayed measurement significantly reduced vascular endothelial growth factor concentrations compared with fresh samples.Conclusions Biomarker-specific methods should be chosen based on ocular fluid type, as collection and preservation effectiveness vary. Factors like patient comfort, time, clinician skill and available resources must also be considered.